Extraction and identification of three major aldose reductase inhibitors from Artemisia montana

Aldose reductase inhibitors (ARIs) provide an important therapeutic and preventive opportunity against hyperglycemia associated diabetic complications. The methanolic extracts of 12 species from the genus Artemisia exhibited significant in vitro rat lens AR (RLAR) inhibitory activities with IC50 val...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Food and chemical toxicology 2011-02, Vol.49 (2), p.376-384
Hauptverfasser: Jung, Hyun Ah, Islam, M.D. Nurul, Kwon, Yong Soo, Jin, Seong Eun, Son, You Kyung, Park, Jin Ju, Sohn, Hee Sook, Choi, Jae Sue
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 384
container_issue 2
container_start_page 376
container_title Food and chemical toxicology
container_volume 49
creator Jung, Hyun Ah
Islam, M.D. Nurul
Kwon, Yong Soo
Jin, Seong Eun
Son, You Kyung
Park, Jin Ju
Sohn, Hee Sook
Choi, Jae Sue
description Aldose reductase inhibitors (ARIs) provide an important therapeutic and preventive opportunity against hyperglycemia associated diabetic complications. The methanolic extracts of 12 species from the genus Artemisia exhibited significant in vitro rat lens AR (RLAR) inhibitory activities with IC50 values ranging from 0.51 to 13.45μg/mL (quercetin, 0.64μg/mL). Since the whole plant of Artemisia montana showed the highest RLAR inhibitory activity, bioassay-guided fractionation was performed to obtain ethyl acetate and n-butanol fractions. Repeated column chromatography of two active fractions, yielded fifteen compounds, including four chlorogenic acids (3,5-di-O-caffeoylquinic acid, chlorogenic acid, neochlorogenic acid, cryptochlorogenic acid), six flavonoids (apigenin, luteolin, quercetin, isoquercitrin, hyperoside, luteolin 7-rutinoside), and five coumarins (umbelliferone, scoparone, scopoletin, esculetin, and scopolin); their structures were confirmed by spectroscopic methods. 3,5-Di-O-caffeoylquinic acid and chlorogenic acid, as well as test flavonoids, displayed the most potent RLAR inhibitory activities with IC50 values ranging from 0.19 to 5.37μM. Furthermore, the HPLC profiles of the ethyl acetate and n-butanol fractions indicated that 3,5-di-O-caffeoylquinic acid, chlorogenic acid, and hyperoside, as major compounds, might play crucial roles in RLAR inhibition. The results suggest that A. montana and three key AR inhibitors therein would clearly be potential candidates as therapeutic or preventive agents for diabetic complications.
doi_str_mv 10.1016/j.fct.2010.11.012
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_860380251</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0278691510006708</els_id><sourcerecordid>848314322</sourcerecordid><originalsourceid>FETCH-LOGICAL-c438t-39994173e41d49dfc33f64faa9e4d6e96c2207450fb0002beda2906f2c65fcac3</originalsourceid><addsrcrecordid>eNqFkU-PFCEQxYnRuOPqB_CifTGeZqSAppt42mzWP8kmHnTPpAYKl0l3swKz0W8v44x60xNQ-VXV4z3GngPfAAf9ZrcJrm4EP7xhw0E8YCsYB7nWsoeHbMXFMK61gf6MPSllxzkfYNCP2ZkAbsTQw4rZq-81o6sxLR0uvouelhpDdPirlEJXbzNRN-Mu5Q4nnwp1mfzeVWy3uNzGbawply7kNHcXudIcS8RuTkvFBZ-yRwGnQs9O5zm7eXf15fLD-vrT-4-XF9drp-RY19IYo2CQpMAr44OTMmgVEA0pr8loJwQfVM_Dtv1CbMmjMFwH4XQfHDp5zl4f597l9G1Ppdomw9E04UJpX-youRy56OH_pBolKClEI-FIupxKyRTsXY4z5h8WuD0EYHe2BWAPAVgA2wJoPS9O0_fbmfyfjt-ON-DVCcDicAoZFxfLX06OUhkwjXt55AImi19zY24-t0095zAobngj3h4Jar7eR8q2uEiLIx8zNVk-xX8I_QnYN6zH</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>848314322</pqid></control><display><type>article</type><title>Extraction and identification of three major aldose reductase inhibitors from Artemisia montana</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Jung, Hyun Ah ; Islam, M.D. Nurul ; Kwon, Yong Soo ; Jin, Seong Eun ; Son, You Kyung ; Park, Jin Ju ; Sohn, Hee Sook ; Choi, Jae Sue</creator><creatorcontrib>Jung, Hyun Ah ; Islam, M.D. Nurul ; Kwon, Yong Soo ; Jin, Seong Eun ; Son, You Kyung ; Park, Jin Ju ; Sohn, Hee Sook ; Choi, Jae Sue</creatorcontrib><description>Aldose reductase inhibitors (ARIs) provide an important therapeutic and preventive opportunity against hyperglycemia associated diabetic complications. The methanolic extracts of 12 species from the genus Artemisia exhibited significant in vitro rat lens AR (RLAR) inhibitory activities with IC50 values ranging from 0.51 to 13.45μg/mL (quercetin, 0.64μg/mL). Since the whole plant of Artemisia montana showed the highest RLAR inhibitory activity, bioassay-guided fractionation was performed to obtain ethyl acetate and n-butanol fractions. Repeated column chromatography of two active fractions, yielded fifteen compounds, including four chlorogenic acids (3,5-di-O-caffeoylquinic acid, chlorogenic acid, neochlorogenic acid, cryptochlorogenic acid), six flavonoids (apigenin, luteolin, quercetin, isoquercitrin, hyperoside, luteolin 7-rutinoside), and five coumarins (umbelliferone, scoparone, scopoletin, esculetin, and scopolin); their structures were confirmed by spectroscopic methods. 3,5-Di-O-caffeoylquinic acid and chlorogenic acid, as well as test flavonoids, displayed the most potent RLAR inhibitory activities with IC50 values ranging from 0.19 to 5.37μM. Furthermore, the HPLC profiles of the ethyl acetate and n-butanol fractions indicated that 3,5-di-O-caffeoylquinic acid, chlorogenic acid, and hyperoside, as major compounds, might play crucial roles in RLAR inhibition. The results suggest that A. montana and three key AR inhibitors therein would clearly be potential candidates as therapeutic or preventive agents for diabetic complications.</description><identifier>ISSN: 0278-6915</identifier><identifier>EISSN: 1873-6351</identifier><identifier>DOI: 10.1016/j.fct.2010.11.012</identifier><identifier>PMID: 21092751</identifier><identifier>CODEN: FCTOD7</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>aldehyde reductase ; Aldehyde Reductase - antagonists &amp; inhibitors ; Aldose reductase ; Animals ; apigenin ; Artemisia ; Artemisia - chemistry ; Artemisia montana ; Biological and medical sciences ; Caffeoylquinic acid ; chlorogenic acid ; Compositae ; diabetic complications ; ethyl acetate ; Flavonoids - chemistry ; Flavonoids - pharmacology ; fractionation ; General pharmacology ; high performance liquid chromatography ; HPLC ; hyperglycemia ; Hyperoside ; Inhibitory Concentration 50 ; isoquercitrin ; Lens, Crystalline - enzymology ; luteolin ; Medical sciences ; Molecular Structure ; Pharmacognosy. Homeopathy. Health food ; Pharmacology. Drug treatments ; Plant Extracts - chemistry ; Plant Extracts - pharmacology ; quercetin ; Rats ; Republic of Korea ; scopoletin ; spectroscopy ; umbelliferones</subject><ispartof>Food and chemical toxicology, 2011-02, Vol.49 (2), p.376-384</ispartof><rights>2010 Elsevier Ltd</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2010 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c438t-39994173e41d49dfc33f64faa9e4d6e96c2207450fb0002beda2906f2c65fcac3</citedby><cites>FETCH-LOGICAL-c438t-39994173e41d49dfc33f64faa9e4d6e96c2207450fb0002beda2906f2c65fcac3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0278691510006708$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=23834919$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21092751$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jung, Hyun Ah</creatorcontrib><creatorcontrib>Islam, M.D. Nurul</creatorcontrib><creatorcontrib>Kwon, Yong Soo</creatorcontrib><creatorcontrib>Jin, Seong Eun</creatorcontrib><creatorcontrib>Son, You Kyung</creatorcontrib><creatorcontrib>Park, Jin Ju</creatorcontrib><creatorcontrib>Sohn, Hee Sook</creatorcontrib><creatorcontrib>Choi, Jae Sue</creatorcontrib><title>Extraction and identification of three major aldose reductase inhibitors from Artemisia montana</title><title>Food and chemical toxicology</title><addtitle>Food Chem Toxicol</addtitle><description>Aldose reductase inhibitors (ARIs) provide an important therapeutic and preventive opportunity against hyperglycemia associated diabetic complications. The methanolic extracts of 12 species from the genus Artemisia exhibited significant in vitro rat lens AR (RLAR) inhibitory activities with IC50 values ranging from 0.51 to 13.45μg/mL (quercetin, 0.64μg/mL). Since the whole plant of Artemisia montana showed the highest RLAR inhibitory activity, bioassay-guided fractionation was performed to obtain ethyl acetate and n-butanol fractions. Repeated column chromatography of two active fractions, yielded fifteen compounds, including four chlorogenic acids (3,5-di-O-caffeoylquinic acid, chlorogenic acid, neochlorogenic acid, cryptochlorogenic acid), six flavonoids (apigenin, luteolin, quercetin, isoquercitrin, hyperoside, luteolin 7-rutinoside), and five coumarins (umbelliferone, scoparone, scopoletin, esculetin, and scopolin); their structures were confirmed by spectroscopic methods. 3,5-Di-O-caffeoylquinic acid and chlorogenic acid, as well as test flavonoids, displayed the most potent RLAR inhibitory activities with IC50 values ranging from 0.19 to 5.37μM. Furthermore, the HPLC profiles of the ethyl acetate and n-butanol fractions indicated that 3,5-di-O-caffeoylquinic acid, chlorogenic acid, and hyperoside, as major compounds, might play crucial roles in RLAR inhibition. The results suggest that A. montana and three key AR inhibitors therein would clearly be potential candidates as therapeutic or preventive agents for diabetic complications.</description><subject>aldehyde reductase</subject><subject>Aldehyde Reductase - antagonists &amp; inhibitors</subject><subject>Aldose reductase</subject><subject>Animals</subject><subject>apigenin</subject><subject>Artemisia</subject><subject>Artemisia - chemistry</subject><subject>Artemisia montana</subject><subject>Biological and medical sciences</subject><subject>Caffeoylquinic acid</subject><subject>chlorogenic acid</subject><subject>Compositae</subject><subject>diabetic complications</subject><subject>ethyl acetate</subject><subject>Flavonoids - chemistry</subject><subject>Flavonoids - pharmacology</subject><subject>fractionation</subject><subject>General pharmacology</subject><subject>high performance liquid chromatography</subject><subject>HPLC</subject><subject>hyperglycemia</subject><subject>Hyperoside</subject><subject>Inhibitory Concentration 50</subject><subject>isoquercitrin</subject><subject>Lens, Crystalline - enzymology</subject><subject>luteolin</subject><subject>Medical sciences</subject><subject>Molecular Structure</subject><subject>Pharmacognosy. Homeopathy. Health food</subject><subject>Pharmacology. Drug treatments</subject><subject>Plant Extracts - chemistry</subject><subject>Plant Extracts - pharmacology</subject><subject>quercetin</subject><subject>Rats</subject><subject>Republic of Korea</subject><subject>scopoletin</subject><subject>spectroscopy</subject><subject>umbelliferones</subject><issn>0278-6915</issn><issn>1873-6351</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU-PFCEQxYnRuOPqB_CifTGeZqSAppt42mzWP8kmHnTPpAYKl0l3swKz0W8v44x60xNQ-VXV4z3GngPfAAf9ZrcJrm4EP7xhw0E8YCsYB7nWsoeHbMXFMK61gf6MPSllxzkfYNCP2ZkAbsTQw4rZq-81o6sxLR0uvouelhpDdPirlEJXbzNRN-Mu5Q4nnwp1mfzeVWy3uNzGbawply7kNHcXudIcS8RuTkvFBZ-yRwGnQs9O5zm7eXf15fLD-vrT-4-XF9drp-RY19IYo2CQpMAr44OTMmgVEA0pr8loJwQfVM_Dtv1CbMmjMFwH4XQfHDp5zl4f597l9G1Ppdomw9E04UJpX-youRy56OH_pBolKClEI-FIupxKyRTsXY4z5h8WuD0EYHe2BWAPAVgA2wJoPS9O0_fbmfyfjt-ON-DVCcDicAoZFxfLX06OUhkwjXt55AImi19zY24-t0095zAobngj3h4Jar7eR8q2uEiLIx8zNVk-xX8I_QnYN6zH</recordid><startdate>20110201</startdate><enddate>20110201</enddate><creator>Jung, Hyun Ah</creator><creator>Islam, M.D. Nurul</creator><creator>Kwon, Yong Soo</creator><creator>Jin, Seong Eun</creator><creator>Son, You Kyung</creator><creator>Park, Jin Ju</creator><creator>Sohn, Hee Sook</creator><creator>Choi, Jae Sue</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7U7</scope><scope>C1K</scope></search><sort><creationdate>20110201</creationdate><title>Extraction and identification of three major aldose reductase inhibitors from Artemisia montana</title><author>Jung, Hyun Ah ; Islam, M.D. Nurul ; Kwon, Yong Soo ; Jin, Seong Eun ; Son, You Kyung ; Park, Jin Ju ; Sohn, Hee Sook ; Choi, Jae Sue</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c438t-39994173e41d49dfc33f64faa9e4d6e96c2207450fb0002beda2906f2c65fcac3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>aldehyde reductase</topic><topic>Aldehyde Reductase - antagonists &amp; inhibitors</topic><topic>Aldose reductase</topic><topic>Animals</topic><topic>apigenin</topic><topic>Artemisia</topic><topic>Artemisia - chemistry</topic><topic>Artemisia montana</topic><topic>Biological and medical sciences</topic><topic>Caffeoylquinic acid</topic><topic>chlorogenic acid</topic><topic>Compositae</topic><topic>diabetic complications</topic><topic>ethyl acetate</topic><topic>Flavonoids - chemistry</topic><topic>Flavonoids - pharmacology</topic><topic>fractionation</topic><topic>General pharmacology</topic><topic>high performance liquid chromatography</topic><topic>HPLC</topic><topic>hyperglycemia</topic><topic>Hyperoside</topic><topic>Inhibitory Concentration 50</topic><topic>isoquercitrin</topic><topic>Lens, Crystalline - enzymology</topic><topic>luteolin</topic><topic>Medical sciences</topic><topic>Molecular Structure</topic><topic>Pharmacognosy. Homeopathy. Health food</topic><topic>Pharmacology. Drug treatments</topic><topic>Plant Extracts - chemistry</topic><topic>Plant Extracts - pharmacology</topic><topic>quercetin</topic><topic>Rats</topic><topic>Republic of Korea</topic><topic>scopoletin</topic><topic>spectroscopy</topic><topic>umbelliferones</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jung, Hyun Ah</creatorcontrib><creatorcontrib>Islam, M.D. Nurul</creatorcontrib><creatorcontrib>Kwon, Yong Soo</creatorcontrib><creatorcontrib>Jin, Seong Eun</creatorcontrib><creatorcontrib>Son, You Kyung</creatorcontrib><creatorcontrib>Park, Jin Ju</creatorcontrib><creatorcontrib>Sohn, Hee Sook</creatorcontrib><creatorcontrib>Choi, Jae Sue</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Food and chemical toxicology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jung, Hyun Ah</au><au>Islam, M.D. Nurul</au><au>Kwon, Yong Soo</au><au>Jin, Seong Eun</au><au>Son, You Kyung</au><au>Park, Jin Ju</au><au>Sohn, Hee Sook</au><au>Choi, Jae Sue</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Extraction and identification of three major aldose reductase inhibitors from Artemisia montana</atitle><jtitle>Food and chemical toxicology</jtitle><addtitle>Food Chem Toxicol</addtitle><date>2011-02-01</date><risdate>2011</risdate><volume>49</volume><issue>2</issue><spage>376</spage><epage>384</epage><pages>376-384</pages><issn>0278-6915</issn><eissn>1873-6351</eissn><coden>FCTOD7</coden><abstract>Aldose reductase inhibitors (ARIs) provide an important therapeutic and preventive opportunity against hyperglycemia associated diabetic complications. The methanolic extracts of 12 species from the genus Artemisia exhibited significant in vitro rat lens AR (RLAR) inhibitory activities with IC50 values ranging from 0.51 to 13.45μg/mL (quercetin, 0.64μg/mL). Since the whole plant of Artemisia montana showed the highest RLAR inhibitory activity, bioassay-guided fractionation was performed to obtain ethyl acetate and n-butanol fractions. Repeated column chromatography of two active fractions, yielded fifteen compounds, including four chlorogenic acids (3,5-di-O-caffeoylquinic acid, chlorogenic acid, neochlorogenic acid, cryptochlorogenic acid), six flavonoids (apigenin, luteolin, quercetin, isoquercitrin, hyperoside, luteolin 7-rutinoside), and five coumarins (umbelliferone, scoparone, scopoletin, esculetin, and scopolin); their structures were confirmed by spectroscopic methods. 3,5-Di-O-caffeoylquinic acid and chlorogenic acid, as well as test flavonoids, displayed the most potent RLAR inhibitory activities with IC50 values ranging from 0.19 to 5.37μM. Furthermore, the HPLC profiles of the ethyl acetate and n-butanol fractions indicated that 3,5-di-O-caffeoylquinic acid, chlorogenic acid, and hyperoside, as major compounds, might play crucial roles in RLAR inhibition. The results suggest that A. montana and three key AR inhibitors therein would clearly be potential candidates as therapeutic or preventive agents for diabetic complications.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>21092751</pmid><doi>10.1016/j.fct.2010.11.012</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0278-6915
ispartof Food and chemical toxicology, 2011-02, Vol.49 (2), p.376-384
issn 0278-6915
1873-6351
language eng
recordid cdi_proquest_miscellaneous_860380251
source MEDLINE; Elsevier ScienceDirect Journals
subjects aldehyde reductase
Aldehyde Reductase - antagonists & inhibitors
Aldose reductase
Animals
apigenin
Artemisia
Artemisia - chemistry
Artemisia montana
Biological and medical sciences
Caffeoylquinic acid
chlorogenic acid
Compositae
diabetic complications
ethyl acetate
Flavonoids - chemistry
Flavonoids - pharmacology
fractionation
General pharmacology
high performance liquid chromatography
HPLC
hyperglycemia
Hyperoside
Inhibitory Concentration 50
isoquercitrin
Lens, Crystalline - enzymology
luteolin
Medical sciences
Molecular Structure
Pharmacognosy. Homeopathy. Health food
Pharmacology. Drug treatments
Plant Extracts - chemistry
Plant Extracts - pharmacology
quercetin
Rats
Republic of Korea
scopoletin
spectroscopy
umbelliferones
title Extraction and identification of three major aldose reductase inhibitors from Artemisia montana
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T16%3A38%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Extraction%20and%20identification%20of%20three%20major%20aldose%20reductase%20inhibitors%20from%20Artemisia%20montana&rft.jtitle=Food%20and%20chemical%20toxicology&rft.au=Jung,%20Hyun%20Ah&rft.date=2011-02-01&rft.volume=49&rft.issue=2&rft.spage=376&rft.epage=384&rft.pages=376-384&rft.issn=0278-6915&rft.eissn=1873-6351&rft.coden=FCTOD7&rft_id=info:doi/10.1016/j.fct.2010.11.012&rft_dat=%3Cproquest_cross%3E848314322%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=848314322&rft_id=info:pmid/21092751&rft_els_id=S0278691510006708&rfr_iscdi=true